opioid analgesic with abuse-deterrent properties

0 marketed 2 in Phase 3

This page covers all opioid analgesic with abuse-deterrent properties drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting mu-opioid receptors, Mu opioid receptor (morphine component); opioid receptors (naltrexone component).

Targets

mu-opioid receptors · Mu opioid receptor (morphine component); opioid receptors (naltrexone component)

Phase 3 pipeline (2)

Oxycodone/Naltrexone Capsules · Elite Laboratories, Inc · Pain Management
Oxycodone/Naltrexone capsules combine an opioid analgesic with an opioid antagonist to provide pain relief while reducing the risk of misuse and dependence.
IPX203 · Impax Laboratories, LLC · Pain Management
IPX203 is an extended-release combination of morphine and naltrexone designed to provide opioid analgesia while reducing the potential for abuse and addiction.